1[1]Kassanos D,Botis D,Rizos D et al.Tissue polypeptide specific antigen throughout normal pregnancy.Anti-Cancer Res,2000,20(3B):2129
2[2]Tramonti G,Ferdeghini M,Donadio C et al.Renal function and serum concentration of five tumor markers (TATI,SCC,CYFRA21-1,TPA and TPS) in patients without evidence of neo-plasia.Cancer Detect Prev,2000,24(1):86
3[3]Kopczynski Z,Thielemann A.The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen Mca and CA15-3 antigen.Eur J Gynaecol Oncol,1998,19(5):503
4[4]Van Dalen A,Barak V,Cremaschi A et al.The prognostic significance of increasinng marker levels in metaststic breast cancer patients with clinically complete remission,partial remission or stable diaease.Int J Biol Markers,1998,13(1):10
5[5]Van Dalen A.TPS monitoring in metastatic breast cancer.Int J Biol Markers,1999,14(1):45
6[6]Padungsutt P,Thirapagawong C,Senapad S et al.Accuracy of tissue polypeptide specific antigen(TPS) in the diagnosis of ovarian malignancy.Anticancer Res,2000,20(2B):1291
7[7]Senapad S,Neungton S,Thirapakawong C et al.Predictive value of the combined serum CA125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.Anticancer Res,2000,20(2B):1297
8[8]Van Dalen A,Favier J,Baumgartner L et al.Prognostic significance of CA125 and TPS levels after chemotherapy in ovarian cancer patients.Anticancer Res,1999,19(4A):2523
9[9]Pina TC,Zapata IT,Lopez JB et al.Tumor markers in lung cancer:does the method of obtaining the cutoff point and reference population influence diagnostic yield?.Clin Biochem,1999,32(6):467
10[10]Nisman B,Lafair J,Heching N et al.Evaluation of tissue polypeptide specific antigen, CYFRA21-1 and carcinoembryonic antigen in nonsmall cell lung carcinoma:does the combined use of cytokeratin markers give any additional information? Cancer,1998,82(10):1850
6Padungsutt P,Thirapagawong C.Accuracy of serum tissue polypeptide specific antigen(TPS) in the diagnosis of ovarian malignancy[J].Anticancer Res,2000,20(2B):1291-1295.
7Muley T,Fetz TH,Dienemann H,et al.Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC[J].Lung Cancer,2008,60(3):408-415.
8Oremek GM,Sauer-Eppel H,Bruzdziak TH.Value of tumour and inflammatory markers in lung cancer[J].Anticancer Res,2007,27(4A):1911-1915.
9Nisman B,Lafair J,Hecheng N,et al.Evaluation of tissue polypeptide specific antigen,CYFRA21-1 and carcinoembryonic antigen in non-small cell lung carcinoma:does the combine use of cytokaratin markers give any additional information?[J].Cancer,1998,82(10):1850.
10Hotta K,Kiura K,Tabata M,et al.Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancer[J].Anticancer Res,2007,27(3B):1737-1741.
